182 related articles for article (PubMed ID: 8434881)
1. Synapse loss in the temporal lobe in Alzheimer's disease.
Scheff SW; Price DA
Ann Neurol; 1993 Feb; 33(2):190-9. PubMed ID: 8434881
[TBL] [Abstract][Full Text] [Related]
2. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity.
DeKosky ST; Scheff SW
Ann Neurol; 1990 May; 27(5):457-64. PubMed ID: 2360787
[TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of synaptic density in the entorhinal cortex in Alzheimer's disease.
Scheff SW; Sparks L; Price DA
Ann Neurol; 1993 Sep; 34(3):356-61. PubMed ID: 8363352
[TBL] [Abstract][Full Text] [Related]
4. Quantitative assessment of cortical synaptic density in Alzheimer's disease.
Scheff SW; DeKosky ST; Price DA
Neurobiol Aging; 1990; 11(1):29-37. PubMed ID: 2325814
[TBL] [Abstract][Full Text] [Related]
5. Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment.
Scheff SW; Price DA; Schmitt FA; Mufson EJ
Neurobiol Aging; 2006 Oct; 27(10):1372-84. PubMed ID: 16289476
[TBL] [Abstract][Full Text] [Related]
6. Temporal cortex synaptophysin mRNA is reduced in Alzheimer's disease and is negatively correlated with the severity of dementia.
Heffernan JM; Eastwood SL; Nagy Z; Sanders MW; McDonald B; Harrison PJ
Exp Neurol; 1998 Apr; 150(2):235-9. PubMed ID: 9527892
[TBL] [Abstract][Full Text] [Related]
7. Altered NCAM expression associated with the cholinergic system in Alzheimer's disease.
Aisa B; Gil-Bea FJ; Solas M; García-Alloza M; Chen CP; Lai MK; Francis PT; Ramírez MJ
J Alzheimers Dis; 2010; 20(2):659-68. PubMed ID: 20164549
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of neuronal lipofuscin in the superior temporal gyrus in Alzheimer's disease do not differ from non-diseased controls: a comparison with disease-related changes in the superior frontal gyrus.
Mountjoy CQ; Dowson JH; Harrington C; Cairns MR; Wilton-Cox H
Acta Neuropathol; 2005 May; 109(5):490-6. PubMed ID: 15759127
[TBL] [Abstract][Full Text] [Related]
9. Impaired coupling of muscarinic M1 receptors to G-proteins in the neocortex is associated with severity of dementia in Alzheimer's disease.
Tsang SW; Lai MK; Kirvell S; Francis PT; Esiri MM; Hope T; Chen CP; Wong PT
Neurobiol Aging; 2006 Sep; 27(9):1216-23. PubMed ID: 16129514
[TBL] [Abstract][Full Text] [Related]
10. Decreasing myelin density reflected increasing white matter pathology in Alzheimer's disease--a neuropathological study.
Sjöbeck M; Haglund M; Englund E
Int J Geriatr Psychiatry; 2005 Oct; 20(10):919-26. PubMed ID: 16163742
[TBL] [Abstract][Full Text] [Related]
11. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
12. Comparing gray matter loss profiles between dementia with Lewy bodies and Alzheimer's disease using cortical pattern matching: diagnosis and gender effects.
Ballmaier M; O'Brien JT; Burton EJ; Thompson PM; Rex DE; Narr KL; McKeith IG; DeLuca H; Toga AW
Neuroimage; 2004 Sep; 23(1):325-35. PubMed ID: 15325380
[TBL] [Abstract][Full Text] [Related]
13. [Neuropathologic investigation in autopsies with special emphasis on findings in Alzheimer's disease].
Leel-Ossy L; Kindler M; Szucs I; Schwarcz T
Ideggyogy Sz; 2006 May; 59(5-6):164-77. PubMed ID: 16786711
[TBL] [Abstract][Full Text] [Related]
14. The possible role of capillary cerebral amyloid angiopathy in Alzheimer lesion development: a regional comparison.
Jeynes B; Provias J
Acta Neuropathol; 2006 Oct; 112(4):417-27. PubMed ID: 16830133
[TBL] [Abstract][Full Text] [Related]
15. Diffusion tensor imaging in early Alzheimer's disease.
Naggara O; Oppenheim C; Rieu D; Raoux N; Rodrigo S; Dalla Barba G; Meder JF
Psychiatry Res; 2006 Apr; 146(3):243-9. PubMed ID: 16520023
[TBL] [Abstract][Full Text] [Related]
16. Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.
Leuba G; Vernay A; Zimmermann V; Saini K; Kraftsik R; Savioz A
Brain Res Bull; 2009 Oct; 80(4-5):196-202. PubMed ID: 19559767
[TBL] [Abstract][Full Text] [Related]
17. The medial temporal lobe in dementia with Lewy bodies: a comparative study with Alzheimer's disease.
Lippa CF; Johnson R; Smith TW
Ann Neurol; 1998 Jan; 43(1):102-6. PubMed ID: 9450774
[TBL] [Abstract][Full Text] [Related]
18. In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease.
Baron JC; Chételat G; Desgranges B; Perchey G; Landeau B; de la Sayette V; Eustache F
Neuroimage; 2001 Aug; 14(2):298-309. PubMed ID: 11467904
[TBL] [Abstract][Full Text] [Related]
19. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
20. Focal decline of cortical thickness in Alzheimer's disease identified by computational neuroanatomy.
Lerch JP; Pruessner JC; Zijdenbos A; Hampel H; Teipel SJ; Evans AC
Cereb Cortex; 2005 Jul; 15(7):995-1001. PubMed ID: 15537673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
